Susceptibility of rabbits to SARS-CoV-2.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 29 12 2020
medline: 27 1 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Transmission of severe acute respiratory coronavirus-2 (SARS-CoV-2) between livestock and humans is a potential public health concern. We demonstrate the susceptibility of rabbits to SARS-CoV-2, which excrete infectious virus from the nose and throat upon experimental inoculation. Therefore, investigations on the presence of SARS-CoV-2 in farmed rabbits should be considered.

Identifiants

pubmed: 33356979
doi: 10.1080/22221751.2020.1868951
pmc: PMC7832544
doi:

Substances chimiques

Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Virol. 2020 Aug 31;94(18):
pubmed: 32661139
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8388-92
pubmed: 7667300
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
PLoS Pathog. 2021 May 19;17(5):e1009585
pubmed: 34010360
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Nat Med. 2004 Mar;10(3):290-3
pubmed: 14981511
PLoS Pathog. 2020 Sep 18;16(9):e1008903
pubmed: 32946524
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338

Auteurs

Anna Z Mykytyn (AZ)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Mart M Lamers (MM)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Nisreen M A Okba (NMA)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Tim I Breugem (TI)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Debby Schipper (D)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Petra B van den Doel (PB)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Peter van Run (P)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Geert van Amerongen (G)

Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, the Netherlands.

Leon de Waal (L)

Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, the Netherlands.

Marion P G Koopmans (MPG)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Koert J Stittelaar (KJ)

Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, the Netherlands.

Judith M A van den Brand (JMA)

Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.

Bart L Haagmans (BL)

Viroscience department, Erasmus Medical Center, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH